Effect of sitagliptin on hepatic histological activity and fibrosis of nonalcoholic steatohepatitis patients: a 1-year randomized control trial

MLA

Alam S, et al. “Effect of Sitagliptin on Hepatic Histological Activity and Fibrosis of Nonalcoholic Steatohepatitis Patients: A 1-Year Randomized Control Trial.” Hepatic Medicine: Evidence and Research, vol. ume 10, Apr. 2018, pp. 23–31. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsdoj&AN=edsdoj.9ff9b0975d6c449f8e8f9a1b7e469748&authtype=sso&custid=ns315887.

APA

Alam S, Ghosh J, Mustafa G, Kamal M, & Ahmad N. (2018). Effect of sitagliptin on hepatic histological activity and fibrosis of nonalcoholic steatohepatitis patients: a 1-year randomized control trial. Hepatic Medicine: Evidence and Research, ume 10, 23–31.

Chicago

Alam S, Ghosh J, Mustafa G, Kamal M, and Ahmad N. 2018. “Effect of Sitagliptin on Hepatic Histological Activity and Fibrosis of Nonalcoholic Steatohepatitis Patients: A 1-Year Randomized Control Trial.” Hepatic Medicine: Evidence and Research ume 10 (April): 23–31. http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsdoj&AN=edsdoj.9ff9b0975d6c449f8e8f9a1b7e469748&authtype=sso&custid=ns315887.